Quick Answer
Kairos Pharma, LTD. reported Net Income Loss of -$5.45 million for the year ending 2025.
- Kairos Pharma, LTD. showed a decrease of -109.3% in Net Income Loss from 2024 to 2025.
- This data is from Kairos Pharma, LTD.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Kairos Pharma, LTD.'s Net Income Loss has declined by 200.6%.
- Historical annual values: Fiscal year 2025: -$5.45 million | Fiscal year 2024: -$2.60 million | Fiscal year 2023: -$1.81 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: